GlobeNewswire Inc.··Not SpecifiedAnnexon to Present Pivotal Data Catalyst at Major Healthcare Conference
$ANNX set to showcase ARCHER II Phase 3 results targeting $1B+ geographic atrophy market at BofA Securities conference May 2026.
ANNXclinical trialbiopharmaceutical